Global Helicobacter Pylori Infection Treatment Market Growth (Status and Outlook) 2025-2031

Report ID: 3031479 | Published Date: Apr 2026 | No. of Page: 92 | Base Year: 2025 | Rating: 4.8
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

The global Helicobacter Pylori Infection Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

The Helicobacter pylori (H. pylori) treatment market refers to the market for drugs and therapies used to treat infections caused by the bacteria Helicobacter pylori. H. pylori is a common bacterium that infects the stomach lining and can lead to various gastrointestinal conditions such as gastritis, peptic ulcers, and stomach cancer.

The H. pylori treatment market is significant due to the prevalence of H. pylori infections worldwide and the potential complications associated with untreated infections. Treatment options typically involve a combination of antibiotics, proton pump inhibitors (PPIs), and other medications to eradicate the bacteria and heal the affected tissues.

The market for H. pylori treatment includes various pharmaceutical companies that develop and manufacture antibiotics and PPIs, as well as other healthcare providers involved in diagnosing and treating H. pylori infections. These companies compete to provide effective and safe treatment options and may also invest in research and development to improve therapeutic approaches.

Key Features

United States market for Helicobacter Pylori Infection Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Helicobacter Pylori Infection Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Helicobacter Pylori Infection Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Segmentation by Type

  • Bismuth-quadruple Therapy
  • Concomitant Therapy
  • Levofloxacin Triple Therapy
  • Bismuth Therapy
  • High-dose Dual Therapy

Segmentation by Application

  • Hospitals
  • Diagnostics Laboratories
  • Clinics

Market by Region

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company's Coverage

  • Cumberland Pharmaceuticals
  • Eisai Co.
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Alpha Laboratories
  • Biohit
  • Phathom Pharmaceuticals
  • Redhill Biopharma
  • Takeda Pharmaceuticals
  • AbbVie

Key Questions Addressed in this Report
Frequently Asked Questions
Helicobacter Pylori Infection Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Helicobacter Pylori Infection Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Helicobacter Pylori Infection Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports